Free Trial

AstraZeneca (AZN) News Today

→ Millionaire-Making “Wealth Pattern” Just Repeated on April 22 (From Paradigm Press) (Ad)
Free AZN Stock Alerts
$80.02
-0.81 (-1.00%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 7 at 5:25 PM | marketbeat.com
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Epoch Investment Partners Inc.
Epoch Investment Partners Inc. raised its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,819,965 shares of the company's stock after ac
June 7 at 4:13 PM | investorplace.com
The No-Brainer Buys: 3 Stocks That Are Absolute Must-Owns Right Now
June 7 at 10:59 AM | cnbc.com
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 6 at 5:17 PM | marketbeat.com
1832 Asset Management L.P. Buys 330,310 Shares of AstraZeneca PLC (NASDAQ:AZN)
1832 Asset Management L.P. lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1,598.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 350,978 shares of the company's stock after purchasing an ad
June 5 at 8:32 AM | marketbeat.com
Rafferty Asset Management LLC Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)
Rafferty Asset Management LLC boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 35.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 166,959 shares of the company's stock after acquiring an additio
June 5 at 8:00 AM | businesswire.com
Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment
June 4, 2024 | cnbc.com
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
June 4, 2024 | marketbeat.com
CIBC Asset Management Inc Buys 11,892 Shares of AstraZeneca PLC (NASDAQ:AZN)
CIBC Asset Management Inc raised its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 5.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 223,618 shares of the company's stock after purchasin
June 4, 2024 | prnewswire.com
AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
June 3, 2024 | marketbeat.com
CIBC Private Wealth Group LLC Boosts Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
CIBC Private Wealth Group LLC grew its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,424,914 shares of the company's stock after buying an additional 889
June 3, 2024 | marketbeat.com
AstraZeneca (NASDAQ:AZN) Reaches New 52-Week High at $79.47
AstraZeneca (NASDAQ:AZN) Sets New 12-Month High at $79.47
June 3, 2024 | fool.com
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
June 2, 2024 | marketbeat.com
Cloverfields Capital Group LP Acquires 11,877 Shares of AstraZeneca PLC (NASDAQ:AZN)
Cloverfields Capital Group LP grew its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 46.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,268 shares of the company's stock after buying an add
June 2, 2024 | businesswire.com
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
June 2, 2024 | businesswire.com
IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
June 2, 2024 | businesswire.com
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapy
June 2, 2024 | businesswire.com
ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
June 2, 2024 | fool.com
3 No-Brainer Stocks to Buy in June
June 1, 2024 | marketbeat.com
Eagle Asset Management Inc. Sells 597,005 Shares of AstraZeneca PLC (NASDAQ:AZN)
Eagle Asset Management Inc. trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 30.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,347,965 shares of the company's stock after
June 1, 2024 | marketbeat.com
Short Interest in AstraZeneca PLC (NASDAQ:AZN) Declines By 10.1%
AstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 7,670,000 shares, a decrease of 10.1% from the April 30th total of 8,530,000 shares. Based on an average daily trading volume, of 5,310,000 shares, the short-interest ratio is currently 1.4 days.
June 1, 2024 | americanbankingnews.com
AstraZeneca (NASDAQ:AZN) PT Raised to $85.00 at Argus
May 31, 2024 | marketbeat.com
AstraZeneca PLC (NASDAQ:AZN) Position Boosted by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. grew its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 147,251 shares of the company's stock
May 30, 2024 | marketbeat.com
Sanders Capital LLC Has $988.97 Million Position in AstraZeneca PLC (NASDAQ:AZN)
Sanders Capital LLC increased its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 39.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,684,066 shares of the company's sto
May 30, 2024 | marketbeat.com
AstraZeneca (NASDAQ:AZN) Price Target Increased to $85.00 by Analysts at Argus
Argus boosted their price target on shares of AstraZeneca from $80.00 to $85.00 and gave the stock a "buy" rating in a research note on Thursday.
May 30, 2024 | americanbankingnews.com
The Goldman Sachs Group Begins Coverage on AstraZeneca (NASDAQ:AZN)
May 30, 2024 | fool.com
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
May 30, 2024 | prnewswire.com
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
May 29, 2024 | marketbeat.com
26,252 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Catalytic Wealth RIA LLC
Catalytic Wealth RIA LLC acquired a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 26,252 shares of the company's stock, valued at appro
May 29, 2024 | msn.com
Fusion shareholders give green light to AstraZeneca acquisition
May 29, 2024 | msn.com
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
May 29, 2024 | fool.com
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
May 29, 2024 | fool.com
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
May 28, 2024 | reuters.com
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
May 28, 2024 | msn.com
Why Is AstraZeneca Stock Trading Lower On Tuesday?
May 27, 2024 | msn.com
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27, 2024 | marketbeat.com
US Bancorp DE Has $12.57 Million Stake in AstraZeneca PLC (NASDAQ:AZN)
US Bancorp DE raised its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 20.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 186,629 shares of the company's stock after purchasing an additional 31,252 shares d
May 27, 2024 | markets.businessinsider.com
AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance
May 27, 2024 | businesswire.com
Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
May 27, 2024 | businesswire.com
Datopotamab Deruxtecan Showed Clinically Meaningful Overall Survival Improvement Versus Chemotherapy in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial
May 25, 2024 | marketbeat.com
Orion Portfolio Solutions LLC Raises Stake in AstraZeneca PLC (NASDAQ:AZN)
Orion Portfolio Solutions LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 10.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 140,712 shares o
May 25, 2024 | marketbeat.com
AstraZeneca PLC (NASDAQ:AZN) is Primecap Management Co. CA's 10th Largest Position
Primecap Management Co. CA cut its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 2.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 42,987,075 shares of the company's stock after selling 902,2
May 24, 2024 | finance.yahoo.com
Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
May 23, 2024 | marketbeat.com
Assetmark Inc. Buys 15,642 Shares of AstraZeneca PLC (NASDAQ:AZN)
Assetmark Inc. boosted its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 11.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 154,906 shares of the company's stock after purchasing an additional 1
May 23, 2024 | businesswire.com
AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
May 22, 2024 | prnewswire.com
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies
May 22, 2024 | benzinga.com
Here's How Much You Would Have Made Owning AstraZeneca Stock In The Last 5 Years
May 22, 2024 | marketbeat.com
Wells Fargo & Company MN Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)
Wells Fargo & Company MN raised its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 7.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,045,394 shares of the company's stock
May 22, 2024 | msn.com
Astra Aims to Almost Double Sales to $80 Billion by 2030
May 22, 2024 | businesswire.com
AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​
May 21, 2024 | investopedia.com
AstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'
Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (Ad)

Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from these levels.

But there are at least 10 different coins that I like even better.

AZN Media Mentions By Week

AZN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AZN
News Sentiment
▼
0.94

0.73
▲
Average
Medical
News Sentiment

AZN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AZN Articles
This Week
▼
20

16
▲
AZN Articles
Average Week

Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AZN) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Millionaire-Making “Wealth Pattern” Just Repeated on April 22
If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.
Paradigm Press | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI Hell Will Break Loose [June 30, 2024] …
On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...
Banyan Hill Publishing | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...
Colonial Metals | Sponsored